A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : EMMPRIN / extracellular matrix metalloproteinase inducer

[Related PubMed/MEDLINE]
Total Number of Papers: 304
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   EMMPRIN  (>> Co-occurring Abbreviation)
Long Form:   extracellular matrix metalloproteinase inducer
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 High Plasma sRAGE (Soluble Receptor for Advanced Glycation End Products) Is Associated With Slower Carotid Intima-Media Thickness Progression and Lower Risk for First-Time Coronary Events and Mortality. sRAGE
2019 Metalloproteinases at the surface of small extrcellular vesicles in advanced ovarian cancer: Relationships with ascites volume and peritoneal canceromatosis index. BOTPs, OCPs, sEVs
2019 Role of CD147 (EMMPRIN/Basigin) in Tissue Remodeling. ECM
2019 Structural insights on druggable hotspots in CD147: A bull's eye view. MMP
2018 Acid-electrolyzed functional water induces extracellular matrix metalloproteinase inducer, a possible novel alarmin, secretion from oral squamous cell carcinoma cell lines. FW, LDH, MMPs
2018 beta-1,3-Galactosyl-O-Glycosyl-Glycoprotein beta-1,6-N-Acetylglucosaminyltransferase 3 Increases MCAM Stability, Which Enhances S100A8/A9-Mediated Cancer Motility. ALCAM, GCNT3, MCAM, NPTN
2018 Green tea polyphenol epigallocatechin-3-gallate increases atherosclerotic plaque stability in apolipoprotein E-deficient mice fed a high-fat diet. EGCG, MMP, SMCs
2018 Immunohistochemical expression of extracellular matrix metalloproteinase inducer (EMMPRIN) in normal oral mucosa, oral epithelial dysplasia and oral squamous cell carcinoma. NOM, OED, OSCC
2018 Interaction between the Wnt/beta-catenin signaling pathway and the EMMPRIN/MMP-2, 9 route in periodontitis. DKK1, MMPs, Pg-LPS
10  2018 Properties of Epithelial Cells and Vaginal Secretions in Pregnant Women When Lactobacillus crispatus or Lactobacillus iners Dominate the Vaginal Microbiome. ---
11  2018 The feedback loop of "EMMPRIN/NF-kappaB" worsens atherosclerotic plaque via suppressing autophagy in macrophage. AS, CQ, NF-kappaB, oxLDL, siRNAs, SQSTM1, TEM, WB
12  2018 The role of extracellular matrix metalloproteinase inducer glycosylation in regulating matrix metalloproteinases in periodontitis. ECM, HGF, HIOEC, IF, MMPs, Pg-LPS, RNAi
13  2017 Atorvastatin attenuates plaque vulnerability by downregulation of EMMPRIN expression via COX-2/PGE2 pathway. COX-2, MMP, oxLDL, VPs
14  2017 Curcumin Alleviates oxLDL Induced MMP-9 and EMMPRIN Expression through the Inhibition of NF-kappaB and MAPK Pathways in Macrophages. AMI, MMP-9, UA
15  2017 Downregulation of Extracellular Matrix Metalloproteinase Inducer by scFv-M6-1B9 Intrabody Suppresses Cervical Cancer Invasion Through Inhibition of Urokinase-Type Plasminogen Activator. MMPs, uPA
16  2017 EMMPRIN Inhibits bFGF-Induced IL-6 Secretion in an Osteoblastic Cell Line, MC3T3-E1. bFGF, FW, HeLa, NF-kappaB
17  2017 EMMPRIN overexpression in SVZ neural progenitor cells increases their migration towards ischemic cortex. MMPs, NPCs, SVZ
18  2017 Expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinase-2 and -9 in horses with chronic airway inflammation. BALF, LAI, MMP
19  2017 Extracellular matrix metalloproteinase inducer (EMMPRIN) is a potential biomarker of angiogenesis in proliferative diabetic retinopathy. ELISA, HRMECs, MMPs, PDR, VEGF
20  2017 Human Cytomegalovirus Encoded miR-US25-1-5p Attenuates CD147/EMMPRIN-Mediated Early Antiviral Response. HCMV, IFN-beta, MOI, sCyPA, UTR
21  2017 Overexpression of REIC/Dkk-3 suppresses the expression of CD147 and inhibits the proliferation of human bladder cancer cells. Ad-REIC, CD147, MAPK
22  2017 Targeting CD147 is a Novel Strategy for Antitumor Therapy. ---
23  2017 The clinicopathological significance and prognostic value of EMMPRIN overexpression in cancers: evidence from 39 cohort studies. ---
24  2017 The origin and evolution of Basigin(BSG) gene: A comparative genomic and phylogenetic analysis. BSG, CD147
25  2016 Anacardic acid inhibits gelatinases through the regulation of Spry2, MMP-14, EMMPRIN and RECK. AA, EGF, MAPK, MMP, RECK, Spry2
26  2016 Biological Characteristics of Cluster of Differentiation 147 and Its Relationship with Tumour. CD147
27  2016 CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis. ---
28  2016 Crosstalk Between Human Monocytic U937 Cells and Gingival Fibroblasts in Coculturally Enhanced Matrix Metalloproteinase-2 Expression. HGFs, MMPs
29  2016 Effect of advanced glycation end products, extracellular matrix metalloproteinase inducer and matrix metalloproteinases on type-I collagen metabolism. AGEs, BSA, MMPs
30  2016 EMMPRIN Down-regulating miR-106a/b Modifies Breast Cancer Stem-like Cell Properties via Interaction with Fibroblasts Through STAT3 and HIF-1alpha. ---
31  2016 EMMPRIN expression is involved in the development of interstitial fibrosis and tubular atrophy in human kidney allografts. IF/TA, MMP
32  2016 EMMPRIN, SP1 and microRNA-27a mediate physcion 8-O-beta-glucopyranoside-induced apoptosis in osteosarcoma cells. MMP, PG
33  2016 EMMPRIN-Targeted Magnetic Nanoparticles for In Vivo Visualization and Regression of Acute Myocardial Infarction. AMI, CMR, ECM, IR, MMPs, NAP9
34  2016 Epigallocatechin-3-gallate Increases RXRgamma-mediated Pro-apoptotic and Anti-invasive Effects in Gastrointestinal Cancer Cell Lines. EGCG, RA, RXRgamma
35  2016 Evaluation of gingival crevicular fluid cyclophilin a and extracellular matrix metalloproteinase inducer levels in different periodontal diseases. CP, CypA, GAgP, GCF
36  2016 Exosomes from Cardiomyocyte Progenitor Cells and Mesenchymal Stem Cells Stimulate Angiogenesis Via EMMPRIN. CMPC, MSC
37  2016 Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) promotes lung fibroblast proliferation, survival and differentiation to myofibroblasts. IPF, MMP, NHLF
38  2016 Extracellular matrix metalloproteinase inducer enhances host resistance against pseudomonas aeruginosa infection through MAPK signaling pathway. PA
39  2016 Group B streptococcus alters properties of vaginal epithelial cells in pregnant women. GBS, MMP
40  2016 Hispidulin induces mitochondrial apoptosis in acute myeloid leukemia cells by targeting extracellular matrix metalloproteinase inducer. AML
41  2016 Inhibition of EMMPRIN and MMP-9 Expression by Epigallocatechin-3-Gallate through 67-kDa Laminin Receptor in PMA-Induced Macrophages. EGCG, JNK, PMA
42  2016 Lentivirus mediated RNA interference of EMMPRIN (CD147) gene inhibits the proliferation, matrigel invasion and tumor formation of breast cancer cells. CD147, RNAi, shRNA
43  2016 Nitric Oxide Induces Cardiac Protection by Preventing Extracellular Matrix Degradation through the Complex Caveolin-3/EMMPRIN in Cardiac Myocytes. IR, KO, LG-EMMPRIN, LVEF, MMPs, NO, NOS2
44  2016 Plasma EMMPRIN levels in acute myocardial infarction and stable coronary artery disease. AMI, CAD, NSTEMI, STEMI
45  2016 Spatiotemporal expression of caveolin-1 and EMMPRIN during mouse tooth development. ---
46  2016 Study of the participation of MMP-7, EMMPRIN and cyclophilin A in the pathogenesis of periodontal disease. CypA, MMP-7
47  2016 Vaginal Inflammation: Association between Leukocyte Concentration and Levels of Immune Mediators. HA, hBD-2, Hyal-1, MMP-8, NGAL
48  2015 Deletion of extracellular matrix metalloproteinase inducer/CD147 induces altered cardiac extracellular matrix remodeling in aging mice. KO, LV, MMP, WT
49  2015 Differential expression of lactic acid isomers, extracellular matrix metalloproteinase inducer, and matrix metalloproteinase-8 in vaginal fluid from women with vaginal disorders. BV, CTV, ELISA, MMP-8, VVC
50  2015 Downregulation of MACC1 inhibits invasion, migration and proliferation, attenuates cisplatin resistance and induces apoptosis in tongue squamous cell carcinoma. IHC, MACC1, siRNA, TSCC, uPA
51  2015 EMMPRIN in gynecologic cancers: pathologic and therapeutic aspects. RNAi
52  2015 Extracellular matrix metalloproteinase inducer (EMMPRIN) remodels the extracellular matrix through enhancing matrix metalloproteinases (MMPs) and inhibiting tissue inhibitors of MMPs expression in HPV-positive cervical cancer cells. MMPs, TIMPs
53  2015 Functional relevance of protein glycosylation to the pro-inflammatory effects of extracellular matrix metalloproteinase inducer (EMMPRIN) on monocytes/macrophages. HG-EMMPRIN, LG
54  2015 Functional role of EMMPRIN in the formation and mineralisation of dental matrix in mouse molars. ---
55  2015 Gelatinases and extracellular matrix metalloproteinase inducer are associated with cyclosporin-A-induced attenuation of periodontal degradation in rats. CsA, Lig, micro-CT, MMP
56  2015 Homocysteine elicits an M1 phenotype in murine macrophages through an EMMPRIN-mediated pathway. CD40, HHcy, MMP, ROS
57  2015 How, with whom and when: an overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activity. Bsg, MMPs, MT-MMPs
58  2015 Icaritin inhibits the invasion and epithelial-to-mesenchymal transition of glioblastoma cells by targeting EMMPRIN via PTEN/AKt/HIF-1alpha signalling. EMT, GBM
59  2015 Immunoexpression of EGFR and EMMPRIN in a series of cases of head and neck squamous cell carcinoma. EGFR, HNSCC
60  2015 Increased extracellular matrix metalloproteinase inducer (EMMPRIN) expression in the conjunctival epithelium exposed to antiglaucoma treatments. BAK, CsA, ECM, HE, LE, RFIs
61  2015 Interleukin 18 and extracellular matrix metalloproteinase inducer cross-regulation: implications in acute myocardial infarction. AMI, ECM, IL-18
62  2015 Intracellular Acidosis Promotes Mitochondrial Apoptosis Pathway: Role of EMMPRIN Down-regulation via Specific Single-chain Fv Intrabody. CEA, CRC
63  2015 Knockdown of EMMPRIN improves adverse remodeling mediated by IL-18 in the post-infarcted heart. IL-18, MI, MMP
64  2015 Physcion induces mitochondria-driven apoptosis in colorectal cancer cells via downregulating EMMPRIN. AMPK, CRC, HIF-1alpha
65  2015 Recombinant Multivalent EMMPRIN Extracellular Domain Induces U937 Human Leukemia Cell Apoptosis by Downregulation of Monocarboxylate Transporter 1 and Activation of Procaspase-9. MCT1
66  2015 Regulation of EMMPRIN (CD147) on monocyte subsets in patients with symptomatic coronary artery disease. AMI, CAD
67  2015 Soluble extracellular matrix metalloproteinase inducer (EMMPRIN, EMN) regulates cancer-related cellular functions by homotypic interactions with surface CD147. EMN, EMNR, EMNR, MMP-14
68  2015 Study on extracellular matrix metalloproteinase inducer and human epidermal growth factor receptor-2 protein expression in papillary thyroid carcinoma using a quantum dot-based immunofluorescence technique. HER, LNM
69  2015 Tumor-derived microvesicles mediate human breast cancer invasion through differentially glycosylated EMMPRIN. TMV
70  2015 Upregulation of EMMPRIN (OX47) in Rat Dorsal Root Ganglion Contributes to the Development of Mechanical Allodynia after Nerve Injury. DRG, MMPs, qRT-PCR, SNL
71  2015 Upregulation of extracellular matrix metalloproteinase inducer promotes hypoxia-induced epithelial-mesenchymal transition in esophageal cancer. EMT, HIF
72  2014 ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma. ADAM17, AREG, MMPs, p-ERK, pEGFR, RNAi
73  2014 Circulating levels of soluble EMMPRIN (CD147) correlate with levels of soluble glycoprotein VI in human plasma. CAD, GP, SAP, sCD147, sGPVI
74  2014 Combined inhibition of EMMPRIN and epidermal growth factor receptor prevents the growth and migration of head and neck squamous cell carcinoma cells. EGF, EGFR, HNSCC
75  2014 Curcumin inhibits EMMPRIN and MMP-9 expression through AMPK-MAPK and PKC signaling in PMA induced macrophages. AMI, AMPK, MMP-13, MMP-9, PKC, UA
76  2014 Elevated hyaluronan and extracellular matrix metalloproteinase inducer levels in women with preeclampsia. GH, PE
77  2014 EMMPRIN co-expressed with matrix metalloproteinases predicts poor prognosis in patients with osteosarcoma. MMPs, MT1, OS and DFS
78  2014 EMMPRIN expression in oral squamous cell carcinomas: correlation with tumor proliferation and patient survival. CSS, OSCC
79  2014 EMMPRIN reduction via scFv-M6-1B9 intrabody affects alpha3beta1-integrin and MCT1 functions and results in suppression of progressive phenotype in the colorectal cancer cell line Caco-2. ---
80  2014 Expression of extracellular matrix metalloproteinase inducer (EMMPRIN) in the endometrium of patients with repeated implantation failure after in vitro fertilization. RIF
81  2014 Expression of extracellular matrix metalloproteinase inducer glycosylation and caveolin-1 in healthy and inflamed human gingiva. HG-EMMPRIN, MMPs
82  2014 Extracellular matrix metalloproteinase inducer (EMMPRIN) expression correlates positively with active angiogenesis and negatively with basic fibroblast growth factor expression in epithelial ovarian cancer. bFGF, EOCs, MVD, VEGF
83  2014 Increased CD147 (EMMPRIN) expression in the rat brain following traumatic brain injury. FPI, MMPs
84  2014 Overexpression of EMMPRIN isoform 2 is associated with head and neck cancer metastasis. EMMPRIN-2, Ig, MMP-2, uPA
85  2014 Pathogenic Neisseria meningitidis utilizes CD147 for vascular colonization. ---
86  2014 Synergistic effect of nanosecond pulsed electric field combined with low-dose of pingyangmycin on salivary adenoid cystic carcinoma. ACC, nsPEF, PYM, SACC
87  2014 Targeting of BRAF resistant melanoma via extracellular matrix metalloproteinase inducer receptor. NIR
88  2014 The influence of autologous bone marrow stem cell transplantation on matrix metalloproteinases in patients treated for acute ST-elevation myocardial infarction. ASTAMI, MMP-9
89  2014 The MMP-9 -1562 C/T polymorphism in the presence of metabolic syndrome increases the risk of clinical events in patients with coronary artery disease. CAD, MetS, MMP, TIMP
90  2014 [Relationship between atherosclerotic plaque characteristics and extracellular matrix metalloproteinase inducer and urokinase-type plasminogen activator in patients with coronary artery disease]. ACS, CHD, MFI, SAP, uPA
91  2013 Bone morphogenetic protein 6 expression in oral cavity squamous cell cancer is associated with bone invasion. AJCC, BMP-6, EGFR
92  2013 Clinical significance of leukotriene b4 and extracellular matrix metalloproteinase inducer in acute coronary syndrome. ACS, LTB4, MMPs
93  2013 Correlation between expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinase-2 and cervical lymph node metastasis of nasopharyngeal carcinoma. CN, LNM-NPC, MMP-2, NM-NPC, NPC
94  2013 Decreased tissue levels of cyclophilin A, a cyclosporine a target and phospho-ERK1/2 in simvastatin patients with abdominal aortic aneurysm. AAA, CypA, mRNA
95  2013 Direct contact with bone marrow stromal cells promotes the invasions of SHI-1 leukemia cells. BMSCs, CXCR4, SDF-1, TIMP-2
96  2013 EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas. IHC
97  2013 EMMPRIN is an independent negative prognostic factor for patients with astrocytic glioma. MMPs
98  2013 EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome. 786-suni, MVA, RCC
99  2013 Expression of EMMPRIN modulates mediators of tumor invasion in oral squamous cell carcinoma. EMT, MMPs, SCC
100  2013 Expression of extracellular matrix metalloproteinase inducer and fascin in urinary bladder cancer: Correlation with clinicopathological characteristics. pT, SCC, TCC